Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI), a specialty pharmaceutical company, is focusing their efforts on addressing cancer and other unmet medical needs. With headquarters in Irvine, California, the company employs approximately 65 employees that meticulously strive to bring new drugs through clinical development and regulatory approval. Spectrum’s staff is devoted to promoting excellence and aims to make a difference every day. For further information, visit the Company’s web site at www.spectrumpharm.com.
- 17 years ago
QualityStocks
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
Tags Rodman & Renshaw
Related Post
-
Scalability of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Tailings Model Represents Profitable Mining Approach Throughout The Americas
Sustainable mining company ESGold is stretching beyond its nascent Quebec mine tailings cleanup operation to…
-
QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present Corporate Update at Emerging Growth Conference on Aug. 20
Clene (NASDAQ: CLNN), a clinical-stage biopharmaceutical company developing treatments for neurodegenerative diseases such as ALS and…
-
QualityStocksNewsBreaks – FAVO Capital (OTC: FAVO) Acquires $190 Million Mixed-Use Property 1818 Park in All-Stock Deal
FAVO Capital (OTC: FAVO), a diversified finance company providing alternative revenue-based funding to SMBs, completed its…